A recent study reveals that immunosuppression, or reduced immune response, in prostate cancer is associated with a ...

Onco360 ®, the nation’s leading independent specialty pharmacy, has been selected as a national pharmacy partner by Astellas for Vyloy ® (zolbetuximab-clzb), approved in combination with ...

Given their non-migratory nature within the mineralized matrix, their unique dendrites are crucial for cell-to-cell communication in response to both intracellular and extracellular stimuli, such as ...

Tumor cells transform fibroblasts into cancer-associated fibroblasts, which have an important immunosuppressive activity on which growth, invasion, and metastasis depend. These activated fibroblasts ...

CD BioSciences, a US-based biotechnology company focusing on the development of imaging technologies, is proud to introduce ...

The firms will initially develop a tool to identify NSCLC patients with EGFR mutations who can benefit from targeted therapy.

ELAHERE is the first and only novel therapy approved in the European Union specifically for patients with folate receptor-alpha (FR?) positive, platinum-resistant ovarian cancerELAHERE represents the ...

Using patient blood samples, the research team has been able to detect, for the first time, a specific process that can make ovarian cancer cells resistant to PARPi treatment—a significant ...

These corresponded to different waves of proliferation of mesenchymal, progenitor-like and acinar cells. Pancreas regeneration required a coordinated transition of proliferation between ...

Isolated VSMCs were maintained in low-glucose DMEM (Dulbecco’s modified eagle medium; Gibco BRL, Grand Island, NY) containing 10% fetal bovine serum (Gibco BRL, Grand Island, NY), and cells at ...